Intramuscular bone induction by the simultaneous administration of recombinant human bone morphogenetic protein 2 and bisphosphonate for autobone graft

Tissue Engineering

Volumn 10, Issue 11-12, 2004, Pages 1652-1661

  Chen, Wei Jia ^a   Jingushi, Seiya ^a,b   Hirata, Goh ^a   Matsumoto, Yoshihiro ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; GENETIC ENGINEERING; LIVING SYSTEMS STUDIES; MUSCLE; PROTEINS; TISSUE;

BONE AREA; TARTRATE-RESISTANT ACID PHOSPHATASE (TRAP); VASCULARITY;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; MINODRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BONE GRAFT; BONE REGENERATION; BONE STRENGTH; COMPRESSION; FEMALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RAT; RAT STRAIN; TISSUE ENGINEERING;

EID: 11144245115     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2004.10.1652     Document Type: Article

References (27)

1. Urist, M.R., Lietze, A., and Dawson, E. β-tricalcium phosphate delivery system for bone morphogenetic protein. Clin. Orthop. 187, 277, 1984.
2. Urist, M.R., Nilsson, O., Rasmussen, J., Hirota, W., Lovell, T., Schmalzreid, T., and Finerman, G.A. Bone regeneration under the influence of a bone morphogenetic protein (BMP) β-tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin. Orthop. 214, 295, 1987.
3. Dong, J., Uemura, T., Shirasaki, Y., and Tateishi, T. Promotion of bone formation using highly pure porous β-TCP combined with bone marrow-derived osteoprogenitor cells. Biomaterials 23, 4493, 2002.
4. Boo, J.S., Yamada, Y., Okazaki, Y., Hibino, Y., Okada, K., Hata, K., Yoshikawa, T., Sugiura, Y., and Ueda, M. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J. Craniofac. Surg. 13, 231 (discussion, 240), 2002.
5. Ogose, A., Hotta, T., Hatano, H., Kawashima, H., Tokunaga, K., Endo, N., and Umezu, H. Histological examination of β-tricalcium phosphate graft in human femur. J. Biomed. Mater. Res. 63, 601, 2002.
6. Laffargue, P., Hildebrand, H.F., Rtaimate, M., Frayssinet, P., Amoureux, J.P., and Marchandise, X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tri-calcium phosphate implants in rabbits' bone defects. Bone 25(Suppl.), 55S, 1999.
7. Wu, C.H., Hara, K., and Ozawa, H. Enhanced osteoinduction by intramuscular grafting of BMP-β-TCP compound pellets into murine models. Arch. Histol. Cytol. 55, 97, 1992.
8. 1 coated β-tricalcium phosphate pellets stimulate healing of experimental bone defects of rat calvariae. Oral Dis. 1, 92, 1995.
9. Niedhart, C., Maus, U., Redmann, E., Schmidt-Rohlfing, B., Niethard, F.U., and Siebert, C.H. Stimulation of bone formation with an in situ setting tricalcium phosphate/ rhBMP-2 composite in rats. J. Biomed. Mater. Res. 65A, 17, 2003.
10. Jingushi, S., Urabe, K., Okazaki, K., Hirata, G., Sakai, A., Ikenoue, T., and Iwamoto, Y. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with β-tricalcium phosphate as a carrier: In vivo bone banking for muscle-pedicle autograft. J. Orthop. Sci. 7, 490, 2002.
11. Terheyden, H., Knak, C., Jepsen, S., Palmie, S., and Rueger, D.R. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: An experimental study in miniature pigs. 1. Prefabrication. Int. J. Oral Maxillofac. Surg. 30, 373, 2001.
12. Terheyden, H., Warnke, P., Dunsche, A., Jepsen, S., Brenner, W., Palmie, S., Toth, C., and Rueger, D.R. Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: An experimental study in miniature pigs. 2. Transplantation. Int. J. Oral Maxillofac. Surg. 30, 469, 2001.
13. Alam, M.I., Asahina, I., Ohmamiuda, K., Takahashi, K., Yokota, S., and Enomoto, S. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 22, 1643, 2001.
14. Marukawa, E., Asahina, I., Oda, M., Seto, I., Alam, M., and Enomoto, S. Functional reconstruction of the non-human primate mandible using recombinant human bone morphogenetic protein-2. Int. J. Oral Maxillofac. Surg. 31, 287, 2002.
15. Musgrave, D.S., Pruchnic, R., Wright, V., Bosch, P., Ghivizzani, S.C., Robbins, P.D., and Huard, J. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone 28, 499, 2001.
16. Bosch, P., Musgrave, D.S., Lee, J.Y., Cummins, J., Shuler, T., Ghivizzani, T.C., Evans, T., Robbins, T.D., and Huard, J. Osteoprogenitor cells within skeletal muscle. J. Orthop. Res. 18, 933, 2000.
17. Urist, M.R. Bone: Formation by autoinduction. Science 150, 893, 1965.
18. Urist, M.R., DeLange, R.J., and Finerman, G.A. Bone cell differentiation and growth factors. Science 220, 680, 1983.
19. Franceschi, R.T., and Xiao, G. Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 88, 446, 2003.
20. Ash, P., Loutit, J.F., and Townsend, K.M. Osteoclasts derived from haematopoietic stem cells. Nature 283, 669, 1980.
21. Giuliani, N., Pedrazzoni, M., Negri, G., Passeri, G., Impicciatore, M., and Girasole, G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22, 455, 1998.
22. Vitte, C., Fleisch, H., and Guenther, H.L. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 137, 2324, 1996.
23. Myoung, H., Park, J.Y., and Choung, P.M. Effects of a bisphosphonate on the expression of bone specific genes after autogenous free bone grafting in rats. J. Periodontal Res. 36, 244, 2001.
24. Li, J., Mori, S., Kaji, Y., Mashiba, T., Kawanishi, J., and Norimatsu, H. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J. Bone Miner. Res. 14, 969, 1999.
25. Li, J., Mori, S., Kaji, Y., Kawanishi, J., Akiyama, T., and Norimatsu, H. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J. Bone Miner. Res. 15, 2042, 2000.
26. Li, C., Mori, S., Li, J., Kaji, Y., Akiyama, T., Kawanishi, J., and Norimatsu, H. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J. Bone Miner. Res. 16, 429, 2001.
27. Koivukangas, A., Tuukkanen, J., Kippo, K., Jamsa, T., Hannuniemi, R., Pasanen, I., Vaananen, K., and Jalovaara, P. Long-term administration of clodronate does not prevent fracture healing in rats. Clin. Orthop. 408, 268, 2003.